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A novel fragmentation of metastable peptide [M + H]+ ions is described. Loss of the C- 
terminal amino acid residue is accomqanied by retention of one of the carboxyl oxygens, as 
judged by ‘*O-labeling. The retained 8O label is located at the new C-terminus. Sequential 
mass spectrometric analyses indicate that the structure of the first-generation product ion is 
indistinguishable from that of the [M + H] + ion of the peptide with one fewer amino acid 
residues. Thus, for example, the metastable decompositions of ions of m/z 904 are similar 
whether they correspond to des-Arg9-bradykinin [M + HI+ ions or to fragments derived 
from bradykinin [M + HI+ ions. No corresponding rearrangements have been observed 
for peptides with C-terminal amide or ester functions. The mechanism of this fragmenta- 
tion may be considered to be analogous to that previously suggested for fragmentations 
of [M + alkali metal cation] + ions. For the examples of bradykinin and related peptides, 
the rearrangement is strongly promoted when arginine is the amino acid residue lost. The 
same fragmentation is also favored by the presence of an arginine residue at or near the 
N-terminus. The strong influence of peptide amino acid composition, including residues 
remote from the C-terminus, on the prevalence of this fragmentation suggests mechanistic 
complexities that require further elucidation. (1 Am Sot Mass Spectrom 1990, 1, 249-257) 
T he combination of fast atom bombardment (FAB) and related ionization techniques with tandem mass spectrometry (MS/MS) is making an in- 
creasingly significant contribution to the elucidation of 
the structures of peptides [l-4]. While the sequencing 
of reasonably pure samples of unmodified peptides is 
usually best achieved by methods based on Edman se- 
quencing, the advantages of the MS/MS approach in- 
clude the ability to sequence N-blocked peptides and 
other structural modifications, together with a capabil- 
ity for the handling of mixtures. 
In MS/MS analyses, ion species selected by the 
first mass analyzer are allowed to fragment sponta- 
neously (when metastable precursors are involved) 
or are induced to do so following collision with an 
inert gas such as helium or argon. The conditions 
under which collisional activation and decomposition 
occur are markedly different in different tandem in- 
strument configurations. Thus, for example, in four- 
sector instruments, precursor ions subjected to col- 
lisional activation are generally of high (kiloelectron- 
volt) kinetic energy. In contrast, low (electronvolt) ki- 
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netic energy ions are the precursors in MS/MS exper- 
iments performed with instruments that Incorporate 
an rf-only quadrupole as the decomposition region 
(triple quadrupoles and hybrid sectorlquadrupole in- 
struments). An adequate comparison of the different 
decomposition regimes involves a complex of interre- 
lated parameters [5, 61. For example, in addition to the 
influence on the maximum energy uptake per collision, 
the different energy regimes have a substantial effect 
on the time scale of the activation and decomposition 
processes. Thus, the contributions of metastable decay 
to the fragmentation pattern observed under condi- 
tions of low-energy collision-activated decomposition 
(CAD) in the quadrupole decomposition region of a 
hybrid or triple quadrupole instrument are expected 
to substantially exceed the contributions of the same 
processes to a high-energy CAD spectrum [7]. This 
is arguably a disadvantage in that low-energy decom- 
positions may include prominent rearrangement pro- 
cesses rather than readily interpreted simple fragmen- 
tations, which are more likely to be favored following 
high-energy CAD. Nevertheless, the high sensitivity of 
detection of metastable decompositions together with 
some advantages of hybrids and triple quadrupoles 
with respect to versatility of operation encourage a 
thorough study of the decomposition processes ob- 
served under low-energy conditions. Furthermore, the 
rapid emergence of electrospray as a powerful ioniza- 
tion technique for biomolecules [B-lo] and the simplic- 
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ity of its coupling to quadrupole mass analyzers (and 
therefore triple quadrupoles) suggest the future im- 
portance of understanding decompositions observed 
under low-energy regimes. 
Studies of the high-energy CAD of peptide [M + 
H]+ ions using four-sector instruments (for example, 
refs. l-3) have established the preponderance of prod- 
uct ions arising by cleavages of the peptide chain (des- 
ignated, according to the Roepstorff convention [ll], 
as A-, B-, or C-type ions for charge retention on the 
N-terminal fragment and X-, Y-, or Z-type ions for 
charge retention on the C-terminal fragment). Other 
prominent product ions arise via additional cleavage of 
the side chains of amino acid residues proximal to the 
site of peptide cleavage [E!]. The quality of product 
ion data obtained by low-energy CAD appears to be 
strongly analyte-dependent; diagnostic fragments in- 
clude simple sequence ions together with “midchain 
fragments” corresponding to chain cleavage at two 
points with charge retention on the excised fragment 
[4, 7, 131. [Such fragments may be designated as, for 
example, (AmYn) or (B,Y,), by extension of the sim- 
ple nomenclature.] The contribution of midchain frag- 
ments (which may confuse interpretation unless recog- 
nized as such) appears to be generally minor in high- 
energy CAD spectra. Side-chain-specific ions, on the 
other hand, are observed only at higher collision ener- 
gies [12, 141. 
As part of a program of study of the MS/MS of FAB- 
desorbed peptides using a hybrid instrument, we re- 
cently noted a novel fragmentation of [M + H]+ ions 
derived from angiotensins II and III, observed under 
conditions of low-energy CAD [15]. Loss of the C- 
terminal amino acid residue was accompanied by re- 
tention of one of the carboxyl oxygens (as judged by 
‘so labeling). The resulting product ion of an n-residue 
peptide may therefore be designated [BL_, + OH]. 
This fragmentation is formally equivalent to a frag- 
mentation (yielding [B,_r + cation + OH]) of alkali 
metal-cationized peptides observed by Renner and 
SpiteIler [16], by Tang et al. [17], and by Grese et 
al. [18] and studied in detail by the last group. The 
same fragmentation of [M + Na]+ has recently been 
described by Kulik et al. [19], in apparent ignorance 
of the earlier reports. These authors also noted a sin- 
gle example of the equivalent rearrangement of a pep- 
tide [M + HI+ ion. Following our recognition that the 
principal product ion in the metastable decomposition 
spectrum of bradykinin [M + H]+ was apparently at- 
tributable to the same rearrangment, we have under- 
taken a more extensive study of this fragmentation. 
enkephalin, Arg-Gly-Asp, and Arg-Arg-Leu-lle-Glu- 
Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly were purchased 
from Sigma Chemical Company (St. Louis, MO). N- 
Methyl-bis(trifluoroacetamide) (MBTFA, Pierce, Rock- 
ford, IL), heptafluorobutyric acid (HFBA, Peninsular 
Chemresearch, Inc., Gainesville, FL), and phenyliso- 
thiocyanate (PITC, ICN Pharmaceuticals, Inc., Plain- 
view, NY) were used without further purification. 
Acetylacetone (Fisher, Fair Lawn, NJ), triethylamine 
(Fisher), methyl iodide (ICN Pharmaceuticals), acetyl 
chloride (J. T. Baker, Phillipsburg, NJ), and pyridine 
(Baker) were redistilled under nitrogen prior to use. 
Crs Sep-Paks were purchased from Waters Associates 
(Miord, MA). 
Dimefhylpyrimidylomithyl Derivatives of 
Argin yl Pepf ides 
The dimethylpyrimidylornithyl (DMPO) derivatives 
of bradykinin, Lys’-bradykinin, des-Argq-bradykinin, 
and proctolin were prepared by using a procedure sim- 
ilar to that described by Morris and co-workers [20]. To 
each dry peptide sample (approximately 100 pg) were 
added 20 PL of water, 40 pL of ethanol, and 20 PL of 
triethylamine, and the samples were capped under ar- 
gon and vortexed. AcetyIacetone (40 FL) was added to 
each sample under a stream of argon, and the samples 
were capped under argon, vortexed, and heated at 100 
“C for 1 h. After evaporation under nitrogen, to each 
oily sample were added 100 pL of water and 10 PL of 
glacial acetic acid, and the samples were again heated 
at 100 “C for 12 min to hydrolyze Schiff’s bases, The 
cool samples were extracted three times with 400 pL 
of diethyl ether, and the aqueous samples were evap- 
orated under a stream of nitrogen. The residual oily 
material was dissolved in methanol (25-50 pL) prior to 
FABlMSlMS analysis, for which 1-2-pL portions were 
used. 
Bradykinin, Lys”-bradyklnin, and proctolin were la- 
beled at their C-termini with lBO by acid-catalyzed iso- 
topic exchange. Approximately 100 ag of each peptide 
was dissolved in 25 pL of [rsO]water (98% isotopic pu- 
rity, Cambridge Isotope Laboratories, Woburn, MA). 
Hydrochloric acid (12 M, 1 aL) was added to each sam- 
ple, and the mixtures were allowed to stand at room 
temperature for 72 h. A portion (l-2 pL) of each of 
these mixtures was analyzed by FABIMSIMS. 
Experimental Procedures 
Methyl Ester Preparation 
The peptides bradykinin, des-Arg’-bradykinin, Lysi- 
bradykinin, Lys”-bradykinin, Typo-bradykinin, angio- 
tensin II, angiotensin III, substance I’, substance P 
fragment 2-11, substance P Met-OHI’, proctolin, Leu- 
The methyl esters of bradykinin, [‘80~]bradykinin 
and substance P Met-OH”, were prepared by acid- 
catalyzed esterification. Methanolic HCl (3M) was 
freshly generated by slowly adding 440 PL of acetyl 
chloride (redistilled) to 1.56 mL of methanol under ni- 
J Am Sot Mass Spectrom 1990, 1,249-257 METASTABLE DECOMPOSITION OF PEPTIDE [M + HI+ IONS 251 
trogen at 0 “C and allowing the mixture to react for 30 
min. Approximately 0.5 mL of this solution was added 
to each dry peptide sample (200 pg), and the mixtures 
were vortexed and allowed to stand at room temper- 
ature for 1 h, followed by evaporation under nitrogen 
to dryness. The methylated samples were redissolved 
in 50 .uL of methanol prior to FABiMSlMS analysis. 
Al-TriJ7uoroacetylation 
Lysr-bradykinin, bradykinin-bis-DMPO, and Leu- 
enkephalin were N-trifluoroacetylated with N-methyl- 
bis(trifIuoroacetamide) (MBTFA). To the dry samples 
(l-200 rg) were added 100 pL of chloroform or pyri- 
dine and 30 FL of MBTFA, and the samples were al- 
lowed to stand at room temperature for l-4 h. Simi- 
larly, [i60r]bradykinin (50 ag) was dissolved in 30 ,uL 
of methanol; 200 pL of MBTFA was added, and the 
sample was allowed to stand at room temperature for 
90 min. AlI samples were evaporated to dryness un- 
der nitrogen, with repeated addition of several drops 
of methanol followed by reevaporation under nitrogen. 
0.5 mL to remove methanol, and the sample was di- 
luted with 2 mL of aqueous 1% HFBA. The diluted 
sample was then loaded onto a Cis Sep-Pak that had 
previously been charged with 10 mL of acetonitrile and 
washed with 10 mL of aqueous 0.1% HFBA [24]. After 
it was loaded, the sample was desalted with 10 mL of 
aqueous 0.1% HFBA and then eluted from the Sep- 
Pak with 4 mL of 80% acetonitrile-water-&l% HFBA. 
The eluate was evaporated to dryness under nitrogen. 
Although the overall yield from this reaction was quite 
low, sufficient N-trimethyl-Leu-enkephalin was gener- 
ated to permit MS/MS analysis. 
Manual Edman Degradation 
Des-A&-bradykinin, bradykinin fragment 2-8, and 
substance P Met-OHii fragment 2-11 were prepared by 
single-stage manual Edman degradation of bradykinin, 
des-Arg9-bradykinin, and substance P Met-OH’r, re- 
spectively, using a modified version of the method of 
Tarr [21, 221. Phenylisothiocyanate (PITC) reagent was 
prepared as ethanol-triethylamine-water-PITC 7:l:l:l 
by volume. Approximately 100 pg of each peptide sam- 
ple was dissolved in 20 pL of PITC reagent and heated 
at 50 “C for 10 min. The samples were then evapo- 
rated under nitrogen and dried briefly in vacua. Water 
(10 pL) was added, and the samples were extracted 
with 200 PL of hexane-ethyl acetate 15:1, followed by 
extraction with 200 FL of hexane-ethyl acetate 7:l. Af- 
ter the aqueous samples were evaporated to dryness 
under nitrogen, 10 pL of 12 M HCl was added and the 
samples were again heated at 50 “C for 5 min, evap- 
orated under nitrogen, and dried in vacua for 1 h to 
remove excess I-ICI. Methanol (20 pL) was then added, 
and the samples were heated at 50 ‘C for 3 min, evap- 
orated under nitrogen, and finally redissolved in 25 ILL 
of methanol. 
Metastable decomposition analyses were performed 
on a VG ZAB SEQ hybrid mass spectrometer (VG 
Analytical Ltd., Manchester, UK) with the configura- 
tion BEqQ (B = magnetic sector, E = electric sector, 
q = rf-only quadrupole, Q = quadrupole mass fil- 
ter). The sample was introduced with a conventional 
fast atom bombardment (FAB) probe. The liquid ma- 
trix used was glycerol. The primary FAB beam was 
xenon atoms with energies of 8 keV. The float po- 
tential of the rf-only quadrupole was set to optimize 
the transmission of the precursor ion (i.e., 5-10 V be- 
low the ion source potential). Precursor ion resolu- 
tion was at least unity. The quadrupole mass analyzer 
was operated at l-2 u resolution. The precursor ions 
were selected under mass spectrometer hardware con- 
trol, and the quadrupole was scanned under control of 
the VG 11125OJ data system. Product ion signals were 
acquired with the data system in “multichannel an- 
alyzer” (MCA) mode. Scans were generally of 10 s 
duration, and 5-15 scans were accumulated. Longer 
scan times (up to 45 s) were occasionally employed 
when the precursor ion signal was weak. Mass as- 
signments of the product ion spectra were based on a 
simple two-point linear calibration of the quadrupole 
mass scale. Sequential product ion analyses employed 
a previously described modification that allowed inde- 
pendent manual control of the electric sector potentials 
[15]. In this mode of operation, precursor ions selected 
by B were allowed to decompose in the field-free re- 
gion between B and E. First-generation product ions 
were selected by adjustment of E (mass resolution 150) 
and allowed, in turn, to decompose in q; final product 
ions were recorded by scanning Q as described above. 
N-Trimethyl-Leu-enkephalin 
Leu-enkephahn (1 mg) was dissolved in 2 mL of 50% 
aqueous methanol, and the pH was adjusted to 10.5 
Results and Discussion 
Mass Spectromety 
with 0.3 N methanolic KOH. Methyl iodide (5 rL) was The spectrum of metastable decompositions of [M + 
added, and the mixture was allowed to stand at room H]+ ions derived from bradykinin is dominated by an 
temperature for 7 h, after which the solution was acid- ion of m/z 904 [7]. Although this ion might be at- 
ified with 100 pL of heptafluorobutyric acid (HFBA) tributed to a Yp structure, the spectrum of the [lsOz]- 
[23]. The solution was then evaporated under nitro- labeled analogue (Figure la) shows that it is shifted 
gen until the volume was reduced to approximately by 2 u to m/z 906, indicating retention of only one 
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of the C-terminal carboxyl oxygens. A minor ion of 
m/z 908 is also observed in the spectrum of the la- 
beled analogne and is attributed to the Y[ fragment. 
In the spectrum of the N-trifluoroacetyl (TEA) deriva- 
tive of [1802]bradykinin (Figure lb), the m/z 908 ion 
is unchanged, whereas m/z 906 is shifted to m/z 1002 
(consistent with the ion’s assignment as a fragment re- 
taining the N-terminus). Thus the ion of m/z 904 in the 
metastable decomposition spectrum of bradykinin may 
be attributed almost entirely to the [BL_, + OH] frag- 
mentation (in this case, [BL + OH]) previously observed 
in the low-energy CAD spectrum of angiotensins 11 and 
III [WI. 
A number of bradykinin analogues and other pep- 
tides have been analyzed to assess the prevalence of 
this rearrangement of [M+H]+ ions and to determine 
the influence of structural variations on the relative 
abundance of the rearrangement product. Table 1 lists 
the peptides included in this study and indicates the 
abundance (relative to total product ion current and to 
the corresponding B,_r ion) of the [BL_, + OH] ion 
in each case. AlI the data shown in Table 1 refer to 
decompositions of metastable precursor ions; the float 
potential of the rf-only quadrupole (determining the 
residence time of the precursor ion in the decomposi- 
tion region) was set to maximize the transmission of 
the precursor ion (generally 5-10 V below ion source 
potential). The estimates of relative abundances shown 
in Table 1 are necessarily approximate. Replicate anal- 
yses, however, suggested good reproducibility. Thus, 
the abundance of the rearrangement ion (as a percent- 
age of total product ion current) for the example of 
bradykinin was determined to be 60 f 2 (SD; n = 5). 
Several bradykinin analogues were analyzed to as- 
sess the effect of minor structural variations on the 
prominence of this metastable decomposition. No 
equivalent rearrangement ion (corresponding to either 
[Bk + OH] or [BQ + OCHs]) was observed during anal- 
ysis of bradykinin methyl ester (Table 1). Removal of 
the C-terminal arginine residue (Argg) of bradykinin 
markedly reduced the abundance of the rearrangement 
ion (Figure 2a), whether this was expressed as a per- 
centage of the total product ion signal or relative to the 
corresponding simple 8,-r ion (Table 1). This suggests 
that loss of an arginine residue is particularly favored 
for this rearrangement. 
Perhaps more surprising, a pronounced reduction 
in the prominence of the rearrangement was ob- 
served when the N-terminal arginine residue (Arg’) of 
bradykinin was removed by Edman degradation (Ta- 
ble 1). Further diminution of the significance of the re- 
arrangement followed removal of the second arginine 
residue (Arg9). Conversion of bradykinin to the bis- 
dimethylpyrimidylornithyl derivative (DMPO; Scheme 
I) reduced the abundance of the [I$ + OH] ion; fur- 
ther reduction was observed after N-terminal trifluo- 
roacetylation. Simiiarly, Dh4l’O derivatization of the 
Arg’ residue in des-Argg-bradykinin markedly reduced 
the abundance of the rearrangement ion by compari- 
son with the underivatized peptide. Thus, the struc- 
ture of the peptide N-terminus is apparently influen- 
tial in determining the relative abundance of this C- 
terminal rearrangement ion derived from bradykinin 
and its analogues. This unexpected conclusion was 
further strengthened by analysis of Lysr-bradykinin, 
where the N-terminal arginine residue is substituted 
J Am Sot Mass Spectrom 1990,1,24%257 METASTABLE DECOMPOSITION OF PEPTIDE [M + H]+ IONS 253 
Table 1. Decomposition of metastable peptide [M t H]+ ions to vield [B.‘_t + OH] + rearrangement ions 
Peptide Sequence” Derivativeb 
RI;_, + OH1 
[M+H] + 
m/z m/z i/zi (%BE i/ilB”_,ld 
Bradykinin 
Lys’-bradykinin 
Lys”-bradykinin 
Tyr”-bradykinin 
Des-Arg9-bradykinin 
Des-Arg’-bredykinin 
Bradykinin, fragment 2-8 
Angiotensin III 
Angiotensin II 
Substance P 
Substance P, fragment 2-11 
Substance P Met-OH” 
Substance P Met-OH”, frag. 2-11 
Tridecapeptide 
Proctolin 
Tripeptide 
Leu-enkephalin 
RPPGFSPFR 
KPPGFSPFR 
KRPPGFSPFR 
YRPPGFSPFR 
RPPGFSPF 
PPGFSPFR 
PPGFSPF 
RVYIHPF 
DRVYIHPF 
RPKWQFFGLM (NH2) 
PKPQQFFGLM [NH,) 
RPKPQQFFGLM 
PKPQQFFGLM 
RRLIEDAEYAARG 
RYLPT 
- 
PO21 
Methyl ester 
DMPO 
[‘80~lDMP0 
DMPO, N-TFA 
[‘*Ojlmethyl esterh 
Ii80~1, N-TFA 
_ 
DMPO 
Bis-N-TFA 
_ 
veo*l 
- 
_ 
DMPO 
_ 
_ 
- 
- 
- 
Methyl ester 
_ 
- 
- 
[‘*Q,l 
DMPO 
_ 
DMPO 
1060 904 60 13 
1064 906 60 13 
1074 91Bw n.d.’ n.d.’ 
1188 9688 6 1 
1192 970 6 1 
1266 1064 2 0.5 
1076 918” n.d. n.d. 
1160 1002 53 26 
1032 876 9 4 
1096 876 3 1 
1224 1068 n.d. n.d. 
1188 1032 60 16 
1192 1034 60 16 
1223 1067 60 18 
904 757 10 5 
968 821 0.5 0.5 
904 748 6 3.5 
748 601 1.5 0.5 
931 764 7 3.5 
1046 899 8 2 
1347 1217 n.d. n.d. 
1191 1061 n.d. n.d. 
1348 1217 2 2 
1362 1231 n.d. n.d. 
1192 1061 2 0.1 
1519 1462 n.d. n.d. 
649 548 8 5 
653 550 8 5 
713 612 1 1 
347 232 6 .5 
411 296 3 .25 
556 443 1.5 .03 
a Single-letter nomenclature for amino acids. 
b [‘*021, label incorporated in C-terminal carboxyl group: DMPO. dimethylpyrimidylornithyl: N-TFA, N-trlfluoroacetyl. 
F Ftelatlve abundance of rearrangement ion expressed as a percentage of the total product ion current. 
d Abundance of the rearrangement ion expressed relative to the corresponding 8. , ion. 
‘m/z values quoted are for [B;., + 0CH31 ions; [El;., + OH] ions were also undetectable in these examples. 
’ n.d., not detected. 
Q [B; + OHI isobaric with Y; , relative abundance values for the rearrangement ion calculated from data for the V80~1 analogus. 
h Acid-catalyzed methyl ester formation results in loss of one 180. 
by the less strongly basic lysine; the rearrangement 
ion was observed at reduced abundance. Addition of 
lysine or tyrosine residues to the N-terminus of in- 
tact bradykinin had no effect on the prevalence of 
the rearrangement ion (Table 1). The influence of the 
amino acid composition remote from the site of re- 
arrangement does not appear simply to reflect the 
propensity for charge localization distant from the 
C-terminus. Thus, metastable decomposition of the 
molecular cation of N-trimethyl leucine-enkephalin (a 
quaternary ammonium derivative) gave the [Bi + OH] 
rearrangement ion with an abundance (relative to the 
total product ion current) of 1.5%, which is similar to 
that observed for decomposition of leucine-enkephalin 
[M + H]+ ions. 
The reverse-geometry sectorlquadrupole hybrid ln- 
strument configuration (BeqQ) provides the facility 
for sequential mass spectrometry (MS/MS/MS) using 
the decomposition regions between B and E and in 
cl [25, 261. Our previous sequential product ion anal- 
yses of angiotensin III established that low-energy 
fragmentation of the [BL t OH] first-generation prod- 
uct ion yielded principally the [Bk + OH] fragment 
[15]. This finding suggested that the product of rear- 
rangement possessed a structure corresponding to the 
]M + HI + ion of the peptide with one fewer amino 
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I 
acid residues. This conclusion was further substan- 
tiated in the present work by the direct comparison 
of the metastable decomposition spectra of ions of 
m/z 904 corresponding to either des-Argg-bradykinin 
[M + H] + ions formed in the ion source or [BL + OH] 
ions formed in the second field-free region (between 
B and E) by decomposition of metastable bradykinin 
[M + H]+ ions. The spectra obtained (Figure 2), which 
include a wealth of structural information, show re- 
markable similarities in fragmentation (bear in mind 
the likely differences in internal energies of the m/z 
Scheme I 
DMPO Derivative 
904 species) and provide a strong indication of iden- 
tity of structure. 
The metastable decomposition product ion spec- 
trum of bradykinin bis-DMPO [M + H] + ions (Figure 3) 
included a number of diagnostic fragment ions of com- 
parable abundance, in constrast to the corresponding 
spectrum of the native peptide, which was dominated 
by the [BL + OH] ion (Figure la; Table 1). The spectrum 
illustrates the remarkable extent of structural informa- 
tion that may be obtained, without recourse to colli- 
sional activation of precursor ions, when metastable 
ml2 
Figure 2. Metastable decomposi- 
tion spectra of ions of m/z 904 
corresponding to (a) des-Arg’- 4 
bradyknin [M + H] + ions formed 
in the ion source and (b) [Bi + : 
OH] ions formed in the second 
$ 
: 
field-free region by decomposition 
of bradyknin [M + H] l ions. The 
structural assignments are indi- 
cated. m/z 
J Am Sot Mass Spectmm 1990, 1, 249-257 METASTABLE DECOMPOSlTION OF PEPTIDE [M + HI + IONS 255 
decompositions are allowed to occur on the time scale 
determined by the hybrid MS/MS experiment. Both B 
and Y” series ions are prominent in the spectrum of 
the derivatized peptide. The product ion of m/z 968 
is attributable to the [BL + OH] ion and/or the isobaric 
Yl structure. The corresponding product ion spectrum 
derived from [M + H]+ ions of the bis-DMPO deriva- 
tive of [1802]bradykinin included m/z 970 ([Bi + OH]) 
and m/z 972 (Y:) fragments in the ratio 1:6. 
A number of peptides unrelated in structure to 
bradykinin have also been analyzed (Table 1) to assess 
the occurrence of the same rearrangement ion ([B:-, + 
OH]). The ion is not observed in the metastable decom- 
position spectra of the [M + H]+ ions of substance P or 
its 2-11 fragment, both of which incorporate C-terminal 
amide groups. The rearrangement is observed, albeit 
at low abundance, with the C-terminal carboxyl ana- 
logues. As observed for bradykinin, methyl ester for- 
mation at the C-terminus of these analogues abolishes 
the rearrangement; that is, neither [B:_, + OH] nor 
[BA_, + OCHs] ions are observed. The [B:_, t OH] ion 
was not observed in the product ion spectrum of [M t 
H]+ ions of the tridecapeptide RRLIEDAEYAARG. 
This parallels the observation of Grese et al. [18] with 
[M + Li]+ ions, where no rearrangement was found 
with peptides containing an arginine residue at the 
n - 1 position. 
Additional examples of the occurrence of the 
[B:_, + OH] ion include peptides with three and five 
amino acid residues (Table 1). Figure 4 shows the 
Figure 3. Met&able decomposi- 
tion product ion spectrum of [M + 
H] + ions derived by FAB of brady- 
b kinin bis-DMPO. The structural as- 
signments are indicated. 
metastable decomposition spectrum of the [M + HI+ 
ions of proctolin (RYLPT). In addition to the [BA + OH] 
ion of m/z 548 and a variety of simple cleavage prod- 
ucts, a second-generation rearrangement ion of m/z 
451 ([Bh + OH]) is present. The corresponding spec- 
trum obtained for [‘*Oz]proctolin (not shown) indi- 
cates that the [I%: + OH] was shifted principally by 2 u 
to m/z 550. The incorporation of isO into the second- 
generation rearrangement ion ([Bi t OH]) derived from 
proctolin [M + H] + ions was consistent with the loca- 
tion of 1801 in the C-terminal carboxyl group of the 
first-generation product ([B: + OH]). 
In order to assess parallels between the forma- 
tion of [Bk_, + OH] and [B,_i + Na t OH] [16-181 
ions, the product ion spectra of metastable [M + H]’ 
and [M + Na]+ ions were compared for several pep- 
tides (Table 2). The rearrangement ion is predomi- 
nant in the product ion spectrum of leucine-enkephalin 
[M t Na] + [15, 181 but of minor importance in the 
spectrum of the products of [M t HI+. Conversely, 
[B,_l + cation + OH] is of greater relative abundance 
in the product ion spectrum of [M + H]+ than in that 
of [M t Na]+ for bradykinin. Evidently, the structural 
features that predispose toward these nominally simi- 
lar rearrangements are not the same. 
It is difficult to determine the precise mechanism 
of formation of [B:_, + OH] ions (if, indeed, a single 
mechanism applies); nevertheless, the pertinent exper- 
imental observations (from the present study and our 
previous preliminary work [15]) may be summarized 
+ 
s 
Figure 4. Met&able product ion 
spectrum of proctolin [M + HI+ 
- ions. The structural assignments 
are indicated; the origin of the m/t 
587 peak is not yet known. m/z 
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Table 2. Rearrangement ions by metastable decomposition of [M + H]+ 
and 1M + Nal+ 
Rearrangement ion: m/z (rel. abundance)* 
Precursor ion [B;_, + OH1 [B,_, + Na + OH1 
Bradykinin 
[M+Hl+ 904(60) 
[M+Nal+ _ 926120) 
[‘*02]bradykinin 
[M+Hl+ 906(601 _ 
[M+Nal+ 928120) 
Angiotensin III 
[MtHI+ 784(7) _ 
[M+Nal+ _ 806(5) 
Leu-enkephalin 
[M+H]+ 443(2) - 
[M+Nal+ - 465(901 
Leu-enkephalin N-TFA 
[M+Hl+ 539(l) _ 
[M+Na]+ - 561(75) 
l Expressed as a percentage of the total product ion current. 
as follows. ions. This mechanism is consistent with the obser- 
Formation of the product ion occurs with reten- 
tion of one of the C-terminal carboxyl oxygens, as 
judged by several ‘*O-labeling experiments. 
The structure of the rearrangement ion is appar- 
ently the same as that of the [M + H]+ ion of 
the peptide with one fewer amino acid residues. 
vations of predominant retention of a single 180 la- 
be1 and its location on the new C-terminus. It is fur- 
ther consistent with the apparent requirement for a 
C-terminal carboxyl group (as opposed to a methyl 
ester or amide functionality). The promotion of the 
rearrangement by a C-terminal arginine might be at- 
tributed to stabilization (possibly via a cyclic structure) 
Thus, the fragmentation of [BL_, + OH] ions de- 
rived from bradykinin [M + HI+ (determined by 
MSIMSMS) parallels the fragmentation of .des- 
Arg’-bradykinin [M + H]+ ions. Furthermore, the 
evidence from analyses of [180&ngiotensin III [IS] 
and [‘s02]proctolin indicates that the original IsO 
label is located at the new C-terminus. 
Formation of the rearrangement ion is observed (in 
the examples studied here) only for peptides with 
a C-terminal carboxyl group. 
The prevalence of this rearrangement is dependent 
on which amino acid residue is lost and also on 
other structural features, including the composition 
of the peptide remote from the C-terminus. 
In seeking to explain the [B,_i + Na + OH] re- 
arrangement ion observed as a decomposition prod- 
uct of peptide [M + Na]+ ions, Tang et al. [17] pro- 
posed chelation of the metal ion between two carbonyl 
oxygens. To accommodate the failure to observe re- 
arrangement of methyl ester [M + Na]+ ions, Grese 
et al. [XI] proposed an alternative mechanism involv- 
ing decomposition of the metal salt of the peptide in 
which the site of protonation was remote from the C- 
terminus. The [B:_, + OH] rearrangement ion derived 
from peptide [M + H]+ ions may formally be consid- 
ered to arise via the mechanism shown in Scheme II, 
which resembles the mechanism proposed by Grese 
et al. [18] for the fragmentation of peptide [M + Li]+ 
1 , * 
1 
+H+ 
: k,_, 
Scheme II 
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of the major neutral fragment that is lost. Others of 
our observations, however, are not readily explained 
by the simple mechanism shown in Scheme II, sug- 
gesting a need for caution in drawing detailed mecha- 
nistic conclusions. Thus, the apparent influence of the 
N-terminal structure (or at least of structural features 
remote from the site of rearrangement) would appear 
to require intramolecular interactions that involve fold- 
ing of the peptide chain. 
6. Todd, I’. J.; McLafferty, F. W. In Tandem Mass Spectmmety; 
&Lafferty, F. W., Ed.; Wiley: New York, 1983; p 149. 
7. Gaskell, S. J,; Reilly, M. H. Rapid Commun. Mass Spectrom. 
1988, 2, 188-191. 
Despite the uncertainties of mechanistic interpre- 
tation, recognition of this rearrangement ion in the 
metastable decomposition and low-energy CAD spec- 
tra of peptide [M + H]+ ions may contribute signif- 
icantly to structural analysis, via ready identification 
of the C-terminal amino acid residue. Continuing de- 
velopment of strategies (incorporating isotopic label- 
ing and selective derivatizations) for use in conjunction 
with metastable and low-energy CAD analyses of pep- 
tides and related compounds will provide improved 
facilities for the characterization of unknowns. 
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